Recall: D-0580-2026

Class I - Dangerous

Class IClassification

2026-05-12Initiated

OngoingStatus

SUN PHARMACEUTICAL INDUSTRIES Firm

Product

DOXOrubin Hydrochloride Liposome injection, 50 mg/25 mL (2mg/mL), 25 mL single-dose vials, Sterile, Rx only, Manufactured for: Northstar Rx LLC., Memphis, TN 38141, Manufactured by: Sun Pharmaceutical Ind. Ltd., Halol-Baroda Highway, Halol, Gujarat, India, NDC 72603-200-01.

Reason

Presence of Particulate matter: Particulate matter identified as glass.

Distribution

U.S. Nationwide

Source: FDA drug enforcement report via openFDA (Voluntary: Firm initiated). If you take this product, talk to your pharmacist or doctor before stopping it.